COVID-19 long haulers
With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions.
With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions.
Genomic sequencing efforts are limited in developing countries, but scientists are mobilizing to help
More than a year into the SARS-CoV-2 pandemic, some scientists say the possibility of a lab leak never got a fair look.
Vaccine makers are designing follow-up shots, based on new mutations, to keep the disease at bay
Companies are scrambling to obtain supplies for hundreds of millions of doses of a type of vaccine that has never been made at this scale before
The country’s leading expert on infectious diseases shares his thoughts on resolving the current public health crisis and preparing for the next
Copyright © 2024 | WordPress Theme by MH Themes